Join to View Full Profile
One Barnes-Jewish PlazaSaint Louis, MO 63110
Dr. Salih is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mohamed Salih, MD, is a cardiology specialist based in Saint Louis, MO. He completed his cardiovascular disease fellowship at the Washington University/B-JH/SLCH Consortium and his internal medicine residency at Vanderbilt University Medical Center. Dr. Salih earned his medical degree from the University of Iowa Roy J. and Lucille A. Carver College of Medicine, following a summa cum laude bachelor's degree in neuroscience from George Mason University. He has published several peer-reviewed articles on topics such as cardiac allograft vasculopathy, amyloid cardiomyopathy, and heart transplantation. His work has received citations within the academic community. Dr. Salih's honors include distinctions in leadership and inclusive excellence, as well as membership in the Gold Humanism Honor Society.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2023 - 2026
Vanderbilt University Medical CenterResidency, Internal Medicine, 2020 - 2023
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2020, MD
George Mason UniversityBS, Neuroscience, Summa Cum Laude, Honors College, 2012 - 2015
Certifications & Licensure
MO State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Distinction in Leadership Vanderbilt University Medical Center, 2023
- Achievement in Inclusive Excellence University of Iowa Carver College of Medicine, 2020
- Gold Humanism Honor Society University of Iowa Carver College of Medicine, 2019
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEarly Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.Kaushik Amancherla, Irene D Feurer, Scott A Rega, Andrew Cluckey, Mohamed Salih
Journal of Cardiac Failure. 2024-05-01 - 3 citationsTrends and Outcomes of Patients With Amyloid Cardiomyopathy Listed for Heart Transplantation.Emmanuel Akintoye, Mohamed Salih, Kent Aje, Paulino Alvarez, Frank Sellke
The Canadian Journal of Cardiology. 2022-08-01 - 2 citationsOutcomes of diabetic patients with end-stage heart failure listed for heart transplantation: A propensity-matched analysis.Emmanuel Akintoye, Paulino Alvarez, Mohamed Salih, Frank Sellke, Alexandros Briasoulis
Clinical Transplantation. 2022-04-01
Abstracts/Posters
- Brugada Syndrome Induced by Tyrosine Kinase InhibitorsJackson Burton, Mohamed Salih, Nathan Bekele, Rebecca S. Riepshoff, Marye J. Gleva, Heart Rhythm, Volume 21, Issue 5, 5/17/2024
- Impact of Donor-transmitted Hepatitis C Virus on Development of Early Cardiac Allograft Vasculopathy in the Current Era.Davis J.*, Salih M.*, Cluckey A., Rega S., Feurer I., Shah A., Brinkley M.D., Lindenfeld J., Menachem J., Ooi H., Pedrotty D., Punnoose L., Sacks, S., Wigger M., Zalaw..., The Journal of Heart and Lung Transplantation, 4/1/2022
Authored Content
- Drug-Induced QTc ProlongationMarch 2022
Professional Memberships
- Phi Beta KappaMember
- Member
- Member
- Association of Black Cardiologists - ABCMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
